![](https://leasonellis.com/wp-content/uploads/2023/12/Holiday-Party-150x150.jpg)
Leason Ellis Celebrates the Holidays 2023
2023 年 12 月 22 日![](https://leasonellis.com/wp-content/uploads/2023/12/yuval-marcus-appointed-managing-partner-1200x628-v193-150x150.jpg)
Leason Ellis Appoints Yuval H. Marcus as Managing Partner
2023 年 12 月 29 日IAM 300 Global Leaders 2024 Interviews Elizabeth Barnhard
![](https://leasonellis.com/wp-content/uploads/2023/12/iam-300-global-leaders-2024-interviews-elizabeth-barnhard-1200x628-1.jpg)
As part of its Global Leaders 2024 series, IAM interviewed attorneys at the pinnacle of the patent law profession including Elizabeth Barnhard. Elizabeth chairs the Pharma/Biotech Practice Group of Leason Ellis. In the interview, Elizabeth spoke to a variety of different topics including mentoring young lawyers, opportunities for lawyers in generative AI, and the current state of the IP transactions space. In addressing the most crucial elements of a world-class IP portfolio in the biotech space, she thoughtfully advised that the biologic therapeutics portfolio should protect the biologic itself a well as functional derivatives, formulations, uses, delivery vehicles, manufacturing processes, diagnostic tests, future improvements, and new uses.